$SCWO
374Water Inc Stock $scwo

$scwo Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000165495422014488 Filed on November 01, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$789.0K	$922.7K	$19.00K
YoY Change	5341.66%	4756.41%	-42.01%
Cost Of Revenue	$716.1K	$812.4K	$0.00
YoY Change
Gross Profit	$72.90K	$110.3K	$19.00K
YoY Change		480.69%
Gross Profit Margin	9.24%	11.96%	100.0%
Selling, General & Admin	$1.441M	$905.1K	$455.5K
YoY Change	147.64%	98.72%	469.31%
% of Gross Profit	1976.06%	820.32%	2397.11%
Research & Development	$386.9K	$118.3K	$115.9K
YoY Change	267.64%	2.0%	6562.99%
% of Gross Profit	530.73%	107.18%	610.19%
Depreciation & Amortization	$17.52K	$650.00	$16.03K
YoY Change	-41.09%	-95.95%
% of Gross Profit	24.03%	0.59%	84.37%
Operating Expenses	$1.827M	$1.023M	$571.4K
YoY Change	166.03%	79.09%	6251.57%
Operating Profit	-$1.755M	-$913.0K	-$552.4K
YoY Change		65.28%	-2424.18%
Interest Expense	$65.45K	$160.00	$430.00
YoY Change	20353.12%	-62.79%	-102.15%
% of Operating Profit
Other Income/Expense, Net	-$910.00	$162.00	-$552.0K
YoY Change	-375.76%	-100.03%	-848.25%
Pretax Income	-$1.690M	-$912.8K	-$552.0K
YoY Change	151.57%	65.38%	359.97%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.690M	-$912.8K	-$552.0K
YoY Change	151.57%	65.38%	-848.25%
Net Earnings / Revenue	-214.19%	-98.93%	-2905.05%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	-$7.206K	-$5.610K
COMMON SHARES
Basic Shares Outstanding	126.7M shares	126.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.991M	$8.402M	$6.848M
YoY Change	-46.17%	22.7%	4791.13%
Cash & Equivalents	$4.047M	$2.408M	$6.848M
Short-Term Investments	$1.944M	$5.994M
Other Short-Term Assets	$153.5K	$1.298M	$40.67K
YoY Change	-29.76%	3091.37%	306.7%
Inventory	$1.661M
Prepaid Expenses	$153.5K	$1.298M	$40.67K
Receivables	$918.2K	$35.48K	$12.67K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.724M	$9.865M	$6.901M
YoY Change	-23.14%	42.95%	3959.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$143.1K	$124.6K	$2.195K
YoY Change	14819.6%	5576.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$35.17K	$20.10K
YoY Change		74.98%
Total Long-Term Assets	$1.193M	$1.141M	$1.080M
YoY Change	12.15%	5.6%
TOTAL ASSETS
Total Short-Term Assets	$8.724M	$9.865M	$6.901M
Total Long-Term Assets	$1.193M	$1.141M	$1.080M
Total Assets	$9.917M	$11.01M	$7.981M
YoY Change	-20.11%	37.89%	4594.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.450M	$1.044M	$76.94K
YoY Change	2201.65%	1256.46%	-59.51%
Accrued Expenses
YoY Change
Deferred Revenue	$200.1K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.663M	$1.262M	$100.1K
YoY Change	1825.67%	1160.37%	-47.29%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.663M	$1.262M	$100.1K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.663M	$1.262M	$100.1K
YoY Change	1825.67%	1160.37%	-84.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$7.850M	-$6.160M	-$2.488M
YoY Change	148.42%	147.57%
Common Stock	$12.67K	$12.67K	$12.28K
YoY Change	1.1%	3.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.254M	$9.743M	$7.881M
YoY Change
Total Liabilities & Shareholders Equity	$9.917M	$11.01M	$7.981M
YoY Change	-20.11%	37.89%	4594.68%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$1.690M	-$912.8K	-$552.0K
YoY Change	151.57%	65.38%	-848.25%
Depreciation, Depletion And Amortization	$17.52K	$650.00	$16.03K
YoY Change	-41.09%	-95.95%
Cash From Operating Activities	-$2.351M	-$1.574M	-$581.3K
YoY Change	198.57%	170.85%	626.63%
INVESTING ACTIVITIES
Capital Expenditures	$71.85K	-$118.4K	-$1.130K
YoY Change	6258.41%	10377.88%
Acquisitions
YoY Change
Other Investing Activities	$4.037M	$1.000M	$0.00
YoY Change	20255.82%
Cash From Investing Activities	$3.965M	$882.0K	-$1.130K
YoY Change	18815.6%	-78155.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	25.05K	0.000	1.135M
YoY Change	-99.5%	-100.0%	440.48%
NET CHANGE
Cash From Operating Activities	-2.351M	-1.574M	-581.3K
Cash From Investing Activities	3.965M	882.0K	-1.130K
Cash From Financing Activities	25.05K	0.000	1.135M
Net Change In Cash	1.639M	-692.4K	552.6K
YoY Change	-61.74%	-225.31%	325.05%
FREE CASH FLOW
Cash From Operating Activities	-$2.351M	-$1.574M	-$581.3K
Capital Expenditures	$71.85K	-$118.4K	-$1.130K
Free Cash Flow	-$2.423M	-$1.456M	-$580.2K
YoY Change	207.25%	150.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Investments Investments	0	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	124593	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	959	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	27272	shares
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	980753	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1028114	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	3	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	12667	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	12531	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15894426	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	35170	usd
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Other Assets OtherAssets	34742	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1262157	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	15474566	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1140516	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1063815	usd
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	27272	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q3	us-gaap	Assets Assets	11005304	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	437500	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-912988	usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2021Q4	us-gaap	Assets Assets	12413456	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126680895	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1043660	usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-27866
	dei	Entity Registrant Name EntityRegistrantName	374WATER INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0271109
	dei	Entity Address Address Line1 EntityAddressAddressLine1	701 W Main Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 410
	dei	Entity Address City Or Town EntityAddressCityOrTown	Durham
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	62981	usd
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27701
	dei	City Area Code CityAreaCode	919
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	200109	usd
	dei	Local Phone Number LocalPhoneNumber	888-8194
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
	dei	Trading Symbol TradingSymbol	SCWO
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-552387	usd
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	18388	usd
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	23390	usd
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126680895	shares
CY2022Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	164600	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2022Q3	us-gaap	Investments Investments	5994272	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1297933	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	218466	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	9864788	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	11349641	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000933972
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	86371	usd
CY2022Q3	us-gaap	Liabilities Liabilities	1262157	usd
CY2021Q4	us-gaap	Liabilities Liabilities	86371	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3001583	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2493568	usd
	scwo	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	1285344	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6159975	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3160015	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3971	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9743147	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12327085	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11005304	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12413456	usd
CY2022Q3	us-gaap	Revenues Revenues	922718	usd
CY2021Q3	us-gaap	Revenues Revenues	19000	usd
	us-gaap	Revenues Revenues	2226477	usd
	us-gaap	Revenues Revenues	33600	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	812386	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1962879	usd
	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	110332	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	19000	usd
	us-gaap	Gross Profit GrossProfit	263598	usd
	us-gaap	Gross Profit GrossProfit	33600	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118253	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	115936	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	726602	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	269796	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	435297	usd
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	227790	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1135979	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	405456	usd
CY2022Q3	scwo	Product And Development Expenses ProductAndDevelopmentExpenses	0	usd
CY2021Q3	scwo	Product And Development Expenses ProductAndDevelopmentExpenses	0	usd
	scwo	Product And Development Expenses ProductAndDevelopmentExpenses	0	usd
	scwo	Product And Development Expenses ProductAndDevelopmentExpenses	1399833	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	82752	usd
CY2021Q3	us-gaap	Professional Fees ProfessionalFees	84514	usd
	us-gaap	Professional Fees ProfessionalFees	375313	usd
	us-gaap	Professional Fees ProfessionalFees	245152	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	387018	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	143147	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1027287	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	206931	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1023320	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	571387	usd
	us-gaap	Operating Expenses OperatingExpenses	3265181	usd
	us-gaap	Operating Expenses OperatingExpenses	2527168	usd
CY2022Q3	scwo	Award Income AwardIncome	0	usd
CY2021Q3	scwo	Award Income AwardIncome	0	usd
	scwo	Award Income AwardIncome	0	usd
	scwo	Award Income AwardIncome	0	usd
CY2022Q3	us-gaap	Interest Income Operating InterestIncomeOperating	162	usd
CY2021Q3	us-gaap	Interest Income Operating InterestIncomeOperating	428	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	1617	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	751	usd
CY2022Q3	us-gaap	Other Income OtherIncome	0	usd
CY2021Q3	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	7	usd
	us-gaap	Other Income OtherIncome	0	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	162	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	428	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1624	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	751	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-912826	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-551959	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2999959	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2492817	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-912826	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-551959	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2999959	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2492817	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-850	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-3122	usd
CY2021Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-3122	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3122	usd
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3972	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-915948	usd
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-551959	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3003931	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2492817	usd
CY2022Q3	scwo	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.01
CY2021Q3	scwo	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.01
	scwo	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.02
	scwo	Net Loss Per Share Basic And Diluted NetLossPerShareBasicAndDiluted	-0.03
CY2022Q3	scwo	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	126680895	shares
CY2021Q3	scwo	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	98391746	shares
	scwo	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	126621412	shares
	scwo	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	84283229	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12327085	usd
CY2022Q1	scwo	Conversion Of Preferred Shares To Common Shares Amount ConversionOfPreferredSharesToCommonSharesAmount	-2	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	97558	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-872858	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	11551783	usd
CY2022Q2	us-gaap	Accretion Expense AccretionExpense	138912	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1214275	usd
CY2022Q3	us-gaap	Accretion Expense AccretionExpense	183524	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000933972
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	27272	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	437500	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	126680895	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-27866
	dei	Entity Registrant Name EntityRegistrantName	374WATER INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-0271109
	dei	Entity Address Address Line1 EntityAddressAddressLine1	701 W Main Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 410
	dei	Entity Address City Or Town EntityAddressCityOrTown	Durham
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27701
	dei	City Area Code CityAreaCode	919
	dei	Local Phone Number LocalPhoneNumber	888-8194
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	SCWO
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	126680895	shares
	scwo	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	0	usd
	scwo	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	1285344	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-912826	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11250	usd
CY2021Q1	us-gaap	Accretion Expense AccretionExpense	10433	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-66551	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-44868	usd
CY2021Q2	scwo	Issuance Of Stock Warrants For Development Of Product IssuanceOfStockWarrantsForDevelopmentOfProduct	-1399833	usd
CY2021Q2	scwo	Recapitalization Of The Company Amount RecapitalizationOfTheCompanyAmount	-84225	usd
CY2021Q2	scwo	Series D Preferred Stock Issued For Cash And Settlement Of Accounts Payable Amount SeriesDPreferredStockIssuedForCashAndSettlementOfAccountsPayableAmount	6601745	usd
CY2021Q2	scwo	Exercised Option And Warrants Amount ExercisedOptionAndWarrantsAmount	150345	usd
CY2021Q2	us-gaap	Accretion Expense AccretionExpense	15134	usd
CY2021Q2	scwo	Issuance Of Common Stock For License Rights Amount IssuanceOfCommonStockForLicenseRightsAmount	1073529	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-1874307	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	7237186	usd
CY2021Q3	scwo	Exercised Option And Warrants Amount ExercisedOptionAndWarrantsAmount	1134999	usd
CY2021Q3	us-gaap	Accretion Expense AccretionExpense	60585	usd
CY2021Q3	scwo	Conversion Of Convertible Preferred Shares Into Common Stock Amount ConversionOfConvertiblePreferredSharesIntoCommonStockAmount	0	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-551959	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	7880811	usd
	scwo	Net Losses NetLosses	2999959	usd
	scwo	Net Losses NetLosses	2492817	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	50052	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16314	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	419995	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	86152	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	0	usd
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	1399833	usd
	scwo	Increase Decrease In Accounts Receivable Net Liabilities Assumed Reverse Acquisition IncreaseDecreaseInAccountsReceivableNetLiabilitiesAssumedReverseAcquisition	164600	usd
	scwo	Increase Decrease In Accounts Receivable Net Liabilities Assumed Reverse Acquisition IncreaseDecreaseInAccountsReceivableNetLiabilitiesAssumedReverseAcquisition	-19663	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1079467	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	26185	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	980679	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-78558	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	200109	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-5002	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	22007	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2598193	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1053591	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	5998243	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	125011	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2319	usd
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	usd
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	29536	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1745	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	19826	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6123999	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7391	usd
	scwo	Repayments To Advances From Stockholders RepaymentsToAdvancesFromStockholders	0	usd
	scwo	Repayments To Advances From Stockholders RepaymentsToAdvancesFromStockholders	-15108	usd
	scwo	Proceeds From Sale Of Series D Preferred Shares ProceedsFromSaleOfSeriesDPreferredShares	0	usd
	scwo	Proceeds From Sale Of Series D Preferred Shares ProceedsFromSaleOfSeriesDPreferredShares	6551745	usd
	scwo	Proceeds From Exercise Of Options And Warrants ProceedsFromExerciseOfOptionsAndWarrants	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7821981	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8723192	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6775781	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11131175	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71799	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2407983	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6847580	usd
	scwo	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	133	usd
	scwo	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	0	usd
	us-gaap	Taxes And Licenses TaxesAndLicenses	0	usd
	us-gaap	Taxes And Licenses TaxesAndLicenses	1073529	usd
	scwo	Accounts Payable Settled With Series D Preferred Stock AccountsPayableSettledWithSeriesDPreferredStock	0	usd
	scwo	Accounts Payable Settled With Series D Preferred Stock AccountsPayableSettledWithSeriesDPreferredStock	50000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	29536	usd
	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	14483	usd
	scwo	Accounts Receivable AccountsReceivable	0	usd
	scwo	Accounts Receivable AccountsReceivable	1000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46150	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	83094	usd
	scwo	Net Liability Assumed NetLiabilityAssumed	0	usd
	scwo	Net Liability Assumed NetLiabilityAssumed	-84225	usd
CY2021Q2	scwo	Shares Issued To Former Holder SharesIssuedToFormerHolder	62410452	shares
CY2021Q2	scwo	Merger Effect Description MergerEffectDescription	Immediately following the Merger, Private 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water Inc. After the Merger, the former Private 374Water stockholders owned 64.2% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock which includes the Preferred Stock.
CY2022Q3	scwo	Investments Adjusted Cost InvestmentsAdjustedCost	8358954	usd
	scwo	Unrealized Losses UnrealizedLosses	15052	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	8402255	usd
CY2022Q3	scwo	Cash And Cash Equivalents CashAndCashEquivalents	2466336	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5935919	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
	scwo	Net Income Loss1 NetIncomeLoss1	-2999959	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	2598193	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7821981	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8723192	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	6775781	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11131175	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71799	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2407983	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6847580	usd
	scwo	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	133	usd
	scwo	Conversion Of Stock Amount Issued ConversionOfStockAmountIssued	0	usd
	us-gaap	Taxes And Licenses TaxesAndLicenses	0	usd
	us-gaap	Taxes And Licenses TaxesAndLicenses	1073529	usd
	scwo	Accounts Payable Settled With Series D Preferred Stock AccountsPayableSettledWithSeriesDPreferredStock	0	usd
	scwo	Accounts Payable Settled With Series D Preferred Stock AccountsPayableSettledWithSeriesDPreferredStock	50000	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	usd
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	29536	usd
	us-gaap	Other Expenses OtherExpenses	0	usd
	us-gaap	Other Expenses OtherExpenses	14483	usd
	scwo	Accounts Receivable AccountsReceivable	0	usd
	scwo	Accounts Receivable AccountsReceivable	1000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	0	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-46150	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	83094	usd
	scwo	Net Liability Assumed NetLiabilityAssumed	0	usd
	scwo	Net Liability Assumed NetLiabilityAssumed	-84225	usd
CY2021Q2	scwo	Shares Issued To Former Holder SharesIssuedToFormerHolder	62410452	shares
CY2021Q2	scwo	Merger Effect Description MergerEffectDescription	Immediately following the Merger, Private 374Water changed its name to 374Water Systems Inc and PowerVerde changed its name to 374Water Inc. After the Merger, the former Private 374Water stockholders owned 64.2% of the Company’s issued and outstanding common stock and 53.8% of the Company’s issued and outstanding voting stock which includes the Preferred Stock.
CY2022Q3	scwo	Investments Adjusted Cost InvestmentsAdjustedCost	8358954	usd
	scwo	Unrealized Losses UnrealizedLosses	15052	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	8402255	usd
CY2022Q3	scwo	Cash And Cash Equivalents CashAndCashEquivalents	2466336	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5935919	usd
CY2022Q3	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35480	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2022Q3	scwo	Unbilled Receivable Net UnbilledReceivableNet	129120	usd
CY2021Q4	scwo	Unbilled Receivable Net UnbilledReceivableNet	0	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	64973	usd
CY2022Q3	scwo	Unbilled Receivable Net UnbilledReceivableNet	129120	usd
CY2021Q4	scwo	Unbilled Receivable Net UnbilledReceivableNet	0	usd
CY2022Q3	us-gaap	Depreciation Depreciation	650	usd
	us-gaap	Depreciation Depreciation	1374	usd
CY2021Q3	us-gaap	Capital Capital	6800773	usd
CY2021Q4	us-gaap	Capital Capital	10572	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2488224	usd
	scwo	Net Income Loss1 NetIncomeLoss1	-2492817	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1053591	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	64973	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	64973	usd
CY2022Q3	us-gaap	Depreciation Depreciation	650	usd
	us-gaap	Depreciation Depreciation	1374	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	726602	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	269796	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118253	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	115936	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	726602	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	269796	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	118253	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	115936	usd
CY2022Q3	us-gaap	Capital Capital	8602631	usd
CY2022Q4	us-gaap	Capital Capital	11263270	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6159975	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	64973	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, useful lives of intangible assets, and valuation allowance against deferred tax assets.</p>
CY2022Q3	us-gaap	Capital Capital	8602631	usd
CY2022Q4	us-gaap	Capital Capital	11263270	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6159975	usd
	scwo	Net Income Loss1 NetIncomeLoss1	-2999959	usd
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	2598193	usd
CY2021Q3	us-gaap	Capital Capital	6800773	usd
CY2021Q4	us-gaap	Capital Capital	10572	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2488224	usd
	scwo	Net Income Loss1 NetIncomeLoss1	-2492817	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1062856	usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	1745	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1015923	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	16243	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1062856	usd
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	1745	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	48678	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1015923	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	16243	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	64973	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	64973	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	64973	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	64973	usd
CY2022Q3	scwo	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	739788	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1015923	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	126680895	shares
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1363149	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	27272	shares
	scwo	Weighted Average Remaining Contractual Life Years Ending Balance WeightedAverageRemainingContractualLifeYearsEndingBalance	P2Y2M15D
	scwo	Stock In Excess Percentage Of Outstanding Share StockInExcessPercentageOfOutstandingShare	0.05	pure
	us-gaap	Related Party Costs RelatedPartyCosts	841577	usd
CY2022Q3	scwo	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	739788	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1015923	usd
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1363149	shares
	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	27272	shares
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1956165	usd
CY2021Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.30
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.37
CY2021Q2	scwo	Aggregate Fair Value Of Warrant AggregateFairValueOfWarrant	1399833	usd
CY2021Q4	scwo	Stock Issued Upon Warrant Exercised StockIssuedUponWarrantExercised	3783333	shares
CY2021Q4	scwo	Proceeds From Stock Issued Upon Warrants Exercised Amount ProceedsFromStockIssuedUponWarrantsExercisedAmount	1134499	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	412500	usd
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	2.83
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	437500	usd
	scwo	Weighted Average Remaining Contractual Life Years Beginning Balance WeightedAverageRemainingContractualLifeYearsBeginningBalance	P2Y11M15D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
	scwo	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	412500	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1956165	usd
CY2021Q2	scwo	Number Of Warrant Purchase NumberOfWarrantPurchase	3783333	shares
CY2021Q2	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.30
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.37
CY2021Q2	scwo	Aggregate Fair Value Of Warrant AggregateFairValueOfWarrant	1399833	usd
CY2021Q4	scwo	Stock Issued Upon Warrant Exercised StockIssuedUponWarrantExercised	3783333	shares
CY2021Q4	scwo	Proceeds From Stock Issued Upon Warrants Exercised Amount ProceedsFromStockIssuedUponWarrantsExercisedAmount	1134499	usd
CY2022Q3	scwo	Warrants Outstanding Series One Shares WarrantsOutstandingSeriesOneShares	1250000	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	412500	usd
CY2022Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	2.83
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.50
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	437500	usd
	scwo	Weighted Average Remaining Contractual Life Years Beginning Balance WeightedAverageRemainingContractualLifeYearsBeginningBalance	P2Y11M15D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
	scwo	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1250000	shares
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2.50
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	412500	usd
	scwo	Weighted Average Remaining Contractual Life Years Ending Balance WeightedAverageRemainingContractualLifeYearsEndingBalance	P2Y2M15D
	scwo	Stock In Excess Percentage Of Outstanding Share StockInExcessPercentageOfOutstandingShare	0.05	pure
	us-gaap	Related Party Costs RelatedPartyCosts	841577	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	62858	usd
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	62858	usd
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2022Q3	scwo	Deferred Revenue Percentage DeferredRevenuePercentage	1	pure
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	200109	usd
CY2021Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0	usd
CY2022Q3	scwo	Deferred Revenue Percentage DeferredRevenuePercentage	1	pure

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
scwo-20220930_lab.xml	Edgar Link	unprocessable
0001654954-22-014488-index-headers.html	Edgar Link	pending
0001654954-22-014488-index.html	Edgar Link	pending
0001654954-22-014488.txt	Edgar Link	pending
0001654954-22-014488-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
scwo-20220930.xsd	Edgar Link	pending
scwo_10q.htm	Edgar Link	pending
scwo_10q_htm.xml	Edgar Link	completed
scwo-20220930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending
scwo-20220930_cal.xml	Edgar Link	unprocessable
scwo-20220930_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCWO
374Water Inc Stock $scwo

2022 Q4 Form 10-Q Financial Statement

#000165495422014488 Filed on November 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCWO 374Water Inc Stock $scwo

2022 Q4 Form 10-Q Financial Statement

#000165495422014488 Filed on November 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCWO
374Water Inc Stock $scwo